## TMUS: T-Mobile US, Inc. - XLC: Communication Services

### Executive Summary

No thesis match: MRS_10 -6.0% below STRENGTH zone (3.0-6.0%); RSI 28 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($185.70)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. T-Mobile US stock hits 52-week low at $199.26**
- Source: Investing.com | 20251209T160842 | Neutral | Relevance: 99%
- T-Mobile US Inc.'s stock has reached a new 52-week low of $199.26, a significant drop from its 52-week high of $276.49 and a 14.39% decline over the past year. Despite this, InvestingPro analysis suggests the stock is undervalued, exhibiting fundamental strength with revenue growth and a modest dividend yield. The company recently declared a quarterly dividend and announced a new COO, while analysts have offered mixed but largely positive ratings.

**2. T-Mobile Faces FTC and State AG Referral After Refusing NAD Inquiry Into 5G Capacity Claims**
- Source: | Cord Cutters News | 20251210T190856 | Neutral | Relevance: 99%
- T-Mobile has been referred to the Federal Trade Commission and state Attorneys General by the National Advertising Division (NAD) after the company declined to participate in an inquiry regarding its 5G network capacity claims. The inquiry was initiated following a challenge from AT&T, which argued that T-Mobile's assertions of superior 5G capacity lacked substantiation. T-Mobile cited an ongoing federal lawsuit filed by AT&T against BBB National Programs as its reason for non-participation, leading NAD to escalate the matter to regulatory authorities for potential enforcement action.

**3. T-Mobile US stock hits 52-week low at $199.26 By Investing.com**
- Source: Investing.com Nigeria | 20251209T161241 | Neutral | Relevance: 98%
- T-Mobile US (NASDAQ: TMUS) stock has fallen to a new 52-week low of $199.26, reflecting a 14.39% decline over the past year, despite being considered undervalued by InvestingPro. The company maintains a strong market capitalization and P/E ratio, with management actively buying back shares and a 2.0% dividend yield. Recent developments include a declared quarterly cash dividend, a new Chief Operating Officer, and various analyst upgrades and reiterated Buy ratings, reflecting ongoing efforts to enhance market position and financial performance.

**4. T-Mobile names Jonathan Freier as chief operating officer**
- Source: StreetInsider | 20251209T140841 | Neutral | Relevance: 98%
- T-Mobile US Inc. has appointed Jonathan A. Freier as Chief Operating Officer, effective December 5, 2025. Freier, 50, previously served as president of T-Mobile's Consumer Group and brings over 25 years of telecommunications experience to the role. He started his career in 1994 with Western Wireless, which later became T-Mobile.

**5. T-Mobile US (TMUS) Stock: Wall Street Stays Bullish as 2025 Selloff Deepens â€“ Latest News, Ratings and Forecasts (December 10, 2025)**
- Source: ts2.tech | 20251210T190856 | Somewhat-Bullish | Relevance: 98%
- T-Mobile US (TMUS) is experiencing a volatile end to 2025, with its share price near 52-week lows despite strong fundamentals like record customer growth and raised guidance. Wall Street analysts remain largely bullish, with consensus price targets suggesting 25-40% upside, attributing the disconnect to sector headwinds and temporary market sentiment. The article details updated analyst ratings, insider activity, and T-Mobile's robust Q3 2025 performance, alongside its strategic growth drivers including 5G expansion, the UScellular acquisition, and AI integration.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Morgan Stanley | $260 | $280 | -7% |
| 2025-12-09 | Argus Research | $245 | $275 | -11% |
| 2025-12-02 | Keybanc | $0 | $0 | 0% |
| 2025-11-21 | Oppenheimer | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Morgan Stanley | main | Overweight |
| 2025-12-09 | Argus Research | main | Buy |
| 2025-12-02 | Keybanc | up | Sector Weight |
| 2025-11-21 | Oppenheimer | down | Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($1.98M) |
| Sells | 41 ($148.13M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 21.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Softbank Group Corpo: 4.0% (-29.3%)
- Vanguard Group Inc: 3.8% (+1.5%)
- Blackrock Inc.: 3.5% (+5.3%)
- State Street Corpora: 2.2% (+4.7%)
- Price (T.Rowe) Assoc: 1.9% (+17.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-3.9% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $148M sold (41 transactions in 90 days).
3. Long-term trend broken: trading 18.1% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Balance sheet: $4.8B free cash flow. Analyst sentiment negative (2 target cuts vs 1 raises). Insider selling cluster ($148.1M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $219.8B |
| Beta | 0.44 |
| 52W Range | $194.90 - $276.49 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 16.7 |
| Current P/E | 19.3 |
| YoY Growth | 15.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from -2.0% to -6.0% (-3.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.0pp (needs >3.0% for momentum thesis). Underperforming sector by 6.3pp, stock-specific weakness. Below SMA200 (0.82x), long-term trend not supportive. MACD histogram bearish (-0.59), momentum weakening. RSI oversold at 28, potential bounce setup.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.97% (CS: 4) | Weak |
| RSI_14 | 28.4 | Oversold |
| MACD Histogram | -0.59 | Bearish |
| vs SMA20 | 0.935x | Below |
| vs SMA50 | 0.906x | Below |
| vs SMA200 | 0.819x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $195.32
- **Stop Loss:** $185.70 (4.9% risk)
- **Target:** $204.94 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 103
- **Position Value:** $20,117.96
- **Portfolio %:** 20.12%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-02-04 (Est: $2.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.40 | $2.41 | +0.4% |
| 2025Q2 | $2.67 | $2.84 | +6.3% |
| 2025Q1 | $2.47 | $2.58 | +4.5% |
| 2024Q4 | $2.28 | $2.57 | +12.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*